Novartis acquires cancer drug developer MorphoSys for $2.9 bln

Morphosys AG

05/02/2024 21:52

Feb 5 (Reuters) - Drugmaker Novartis AG  NOVN.S  said on
Monday is has acquired MorphoSys AG  MORG.DE , a developer of
cancer treatments, for 2.7 billion euros. ($2.90 billion)

($1 = 0.9312 euros)

 (Reporting by Urvi Dugar in Bengaluru; Editing by Shilpi
Majumdar)
 ((UrviManoj.Dugar@thomsonreuters.com;))